Brief: Organogenesis Q2 Revenue USD 130.2 Million
08/08/2024 21:05
Aug 08 (Reuters) - Organogenesis Q2 net income USD -17 million. * Q2 adjusted EBITDA USD 15.6 million * Q2 adjusted net income USD 200 thousand * Q2 operating income USD -13.9 million * outlook FY EBITDA USD 2 million * outlook FY adjusted EBITDA USD 16-35 million
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers